Lessons Learned from Experimental Human Model of Zinc Deficiency.
Level 5 - mechanism / opinion, no new human data
Narrative review and historical synthesis of clinical observations and human dietary experiments
PubMed 32411807 · doi:10.1155/2020/9207279
What was done
This narrative review synthesizes historical clinical observations of severe zinc deficiency in Middle Eastern cohorts and findings from an experimental human model of mild dietary zinc deficiency. The model evaluated the timeline of changes in immunological parameters (thymulin activity, IL-2 and IFN-gamma mRNA expression, natural killer cell activity, cytotoxic T-cell activity) relative to zinc concentrations measured in lymphocytes and plasma.
What was found
In the experimental human model of mild zinc deficiency, decreases in thymulin activity and IL-2 mRNA were detected within 8 to 12 weeks after initiating a zinc-deficient diet. Lymphocyte zinc decreased at 20 weeks, and plasma zinc decreased at 24 weeks. Reductions in natural killer cell and cytotoxic T-cell activity were reported with no observed effect on Th2 cell function, indicating a Th1/Th2 functional imbalance. The abstract provides no exact sample sizes, numerical effect sizes, or statistical confidence intervals.
Why it matters
Plasma zinc is a delayed diagnostic marker that misses early marginal zinc deficiency, as Th1-mediated immune dysfunction manifests weeks before circulating zinc concentrations decline. Immunological biomarkers such as thymulin activity or IL-2 expression could enable earlier detection of marginal deficiency.
Limits
The abstract presents a narrative synthesis without systematic search methodology, meta-analytic pooling, sample sizes, participant demographics, exact dietary parameters, comparator groups, or statistical measures of variance.
Cited by
- supports Thymulin levels decline as the first sign of zinc depletion, prior to drops in red blood cell zinc or serum zinc.